NASDAQ: XENEXenon Pharmaceuticals Inc Stock Ownership - Who owns Xenon Pharmaceuticals?
Insider buying vs selling
Have Xenon Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Thomas Patrick Kelly | CFO | 2026-09-30 | 15,000 | $37.32 | $559.74kBuy |
| Ian Mortimer | CEO;Pres | 2026-09-30 | 30,000 | $37.38 | $1.12MBuy |
| Dawn Svoronos | Director | 2026-09-01 | 5,144 | $8.15 | $41.92kBuy |
| Christopher John Kenney | Med | 2026-08-28 | 700 | $60.98 | $42.68kSell |
| Christopher John Kenney | Med | 2026-08-28 | 6,368 | $60.17 | $383.14kSell |
| Steven Gannon | Director | 2026-08-11 | 10,000 | $64.06 | $640.55kSell |
| Gillian Cannon | Director | 2026-06-05 | 1,190 | $53.14 | $63.24kSell |
| Gary Patou | Director | 2026-06-05 | 1,322 | $53.14 | $70.25kSell |
| Steven Gannon | Director | 2026-06-01 | 1,416 | $53.41 | $75.63kSell |
| Dawn Svoronos | Director | 2026-06-01 | 1,416 | $53.41 | $75.63kSell |
XENE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when XENE insiders and whales buy or sell their stock.
XENE Shareholders
What type of owners hold Xenon Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Evan A. Stein | 1.08% | 1,044,103 | $39.92M | Insider |
| Johnston L. Evans | 0.46% | 444,655 | $17.00M | Insider |
| Michael R. Hayden | 0.45% | 437,088 | $16.71M | Insider |
| Frank A. Holler | 0.15% | 147,205 | $5.63M | Insider |
| Ian Mortimer | 0.10% | 92,823 | $3.55M | Insider |
| Michael M. Tarnow | 0.08% | 77,942 | $2.98M | Insider |
| Mohammad Azab | 0.08% | 74,225 | $2.84M | Insider |
| Bvf Partners L P | 0.06% | 59,464 | $2.27M | Insider |
| Simon N. Pimstone | 0.04% | 38,920 | $1.49M | Insider |
| Dawn Svoronos | 0.03% | 31,373 | $1.20M | Insider |
XENE vs Biotech Stocks
Xenon Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.